Journal article
Interleukin-6 receptor antagonists in critically ill patients with Covid-19
- Abstract:
-
Background
The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.Methods
We evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform trial. Adult patients with Covid-19, within 24 hours after starting organ support in the intensive care unit (ICU), were randomly assigned to receive tocilizumab (8 mg per kilogram of body weight)... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Bibliographic Details
- Publisher:
- Massachusetts Medical Society Publisher's website
- Journal:
- New England Journal of Medicine Journal website
- Volume:
- 384
- Issue:
- 16
- Pages:
- 1491-1502
- Publication date:
- 2021-02-25
- Acceptance date:
- 2021-02-09
- DOI:
- EISSN:
-
1533-4406
- ISSN:
-
0028-4793
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1161185
- Local pid:
- pubs:1161185
- Deposit date:
- 2021-02-12
Terms of use
- Copyright holder:
- Massachusetts Medical Society
- Copyright date:
- 2021
- Rights statement:
- Copyright © 2021 Massachusetts Medical Society.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record